Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Call for greater access to animal medicine
drugs
"One of the major reasons attributable for the lack of availability and accessibility of quality veterinary medicines and vaccines is the lack of an appropriate, robust and functioning regulatory system."

Conference highlights the need for government collaboration 

The global animal medicines association, HealthforAnimals, has appealed for greater worldwide access to veterinary medicines. The organisation, speaking at the fifth Global Animal Health Conference in Delhi, urged representatives from 24 countries to improve regional cooperation in order to improve the availability of animal medicines.
 
The conference, supported by the Bill and Melinda Gates Foundation, emphasised the socio-economic benefits of providing farmers with access to quality animal health products. Through enabling access, livestock can be immunised and treated for disease, ensuring the livelihood of communities and protecting against transferable diseases.
 
Opening the conference, Dr. Samuel Thevasagayam, Deputy Director of Agricultural Development at the Bill and Melinda Gates Foundation said:
“Approximately 60 per cent of smallholder farmers depend on livestock for their wellbeing in Africa and South Asia. It is estimated that 25 per cent of livestock production is lost due to preventable or treatable diseases. One of the major reasons attributable for the lack of availability and accessibility of quality veterinary medicines and vaccines is the lack of an appropriate, robust and functioning regulatory system.

“We are working, with our partners in the animal health industry and regulatory agencies, to establish a robust regulatory framework that is effective, transparent and predictable to address this massive need to eliminate the leakage of value from livestock production and help small holder farmers realise the value of livestock by further investing in feed, livestock genetics and improved husbandry.”

Closing the conference, HealthforAnimals’ executive director, Carel du Marchie Sarvaas said: “The purpose of the conference was to bring together people from a range of sectors to help build a greater bond, and in turn, better animal health. A key theme of the day has been harmonisation. Chiefly the need for regulators and governments to collaborate together with other stakeholders.

“Access to quality veterinary medicines not only protect animals but humans, their livelihoods and wellbeing. We hope all those at the conference apply and share today’s learnings to help us all make animals healthier.”
 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.